Abstract
Neoatherosclerosis (NA) within stents has become an important clinical problem after coronary artery stent implantation. In-stent restenosis and in-stent thrombosis are the two major complications following coronary stent placement and seriously affect patient prognosis. As the common pathological basis of these two complications, NA plaques, unlike native atherosclerotic plaques, often grow around residual oxidized lipids and stent struts. The main components are foam cells formed by vascular smooth muscle cells (VSMCs) engulfing oxidized lipids at lipid residue sites. Current research mainly focuses on optical coherence tomography (OCT) and intravascular ultrasound (IVUS), but the specific pathogenesis of NA is still unclear. A thorough understanding of the pathogenesis and pathological features of NA provides a theoretical basis for clinical treatment. This article reviews the previous research of our research group and the current situation of domestic and foreign research.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Yahagi K, Kolodgie FD, Otsuka F, et al. Pathophysiology of native coronary, vein graft, and in-stent atherosclerosis. Nat Rev Cardiol, 2016,13(2):79–98
Mazin I, Paul G, Asher E, et al. Neoatherosclerosis - From basic concept to clinical implication. Thromb Res, 2019,178:12–16
Borovac JA, D’Amario D, Vergallo R, et al. Neoatherosclerosis after drug-eluting stent implantation: a novel clinical and therapeutic challenge. Eur Heart J Cardiovasc Pharmacother, 2019,5(2):105–116
Libby P. Inflammation in Atherosclerosis—No Longer a Theory. Clin Chem, 2021,67(1):131–142
Libby P. Targeting Inflammatory Pathways in Cardiovascular Disease: The Inflammasome, Interleukin-1, Interleukin-6 and Beyond. Cells, 2021,10(4):951
Raggi P, Genest J, Giles JT, et al. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions. Atherosclerosis, 2018,276:98–108
Libby P, Ridker PM, Hansson GK. Progress and challenges in translating the biology of atherosclerosis. Nature, 2011,473(7347):317–325
Chen ZY, Matsumura M, Mintz GS, et al. Prevalence and Impact of Neoatherosclerosis on Clinical Outcomes After Percutaneous Treatment of Second-Generation Drug-Eluting Stent Restenosis. Circ Cardiovasc Interv, 2022,15(9):e011693
Mach F, Baigent C, Catapano AL, et al. 2019 ESC/EAS Guidelines for the management of dyslipidemias: lipid modification to reduce cardiovascular risk. Eur Heart J, 2020,41(1):111–188
Raber L, Serruys PW. Late vascular response following drug-eluting stent implantation. JACC Cardiovasc Interv, 2011,4(10):1075–1078
Andreou I, Stone PH. In-Stent Atherosclerosis at a Crossroads: Neoatherosclerosis or Paleoatherosclerosis? Circulation, 2016, 134(19):1413–1415
Yuan X, Jiang M, Feng H, et al. The effect of sex differences on neointimal characteristics of in-stent restenosis in drug-eluting stents: An optical coherence tomography study. Heliyon, 2023,9(8):e19073
Nakamura D, Dohi T, Ishihara T, et al. Predictors and outcomes of neoatherosclerosis in patients with in-stent restenosis. EuroIntervention, 2021,17(6):489–496
Lee SY, Hur SH, Lee SG, et al. Optical coherence tomographic observation of in-stent neoatherosclerosis in lesions with more than 50% neointimal area stenosis after second-generation drug-eluting stent implantation. Circ Cardiovasc Interv, 2015,8(2):e001878
Torii R, Stettler R, Raber L, et al. Implications of the local hemodynamic forces on the formation and destabilization of neoatherosclerotic lesions. Int J Cardiol, 2018,272:7–12
Torii S, Jinnouchi H, Sakamoto A, et al. Drug-eluting coronary stents: insights from preclinical and pathology studies. Nat Rev Cardiol, 2020,17(1):37–51
Otsuka F, Byrne RA, Yahagi K, et al. Neoatherosclerosis: overview of histopathologic findings and implications for intravascular imaging assessment. Eur Heart J, 2015,36(32):2147–2159
Nakazawa G, Otsuka F, Nakano M, et al. The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents. J Am Coll Cardiol, 2011,57(11):1314–1322
Jang IK, Tearney GJ, MacNeill B, et al. In vivo characterization of coronary atherosclerotic plaque by use of optical coherence tomography. Circulation, 2005,111(12):1551–1555
Nakamura D, Attizzani GF, Toma C, et al. Failure Mechanisms and Neoatherosclerosis Patterns in Very Late Drug-Eluting and Bare-Metal Stent Thrombosis. Circ Cardiovasc Interv, 2016,9(9):e003785
Yabushita H, Bouma BE, Houser SL, et al. Characterization of human atherosclerosis by optical coherence tomography. Circulation, 2002,106(13):1640–1645
Ali ZA, Roleder T, Narula J, et al. Increased thin-cap neoatheroma and periprocedural myocardial infarction in drug-eluting stent restenosis: multimodality intravascular imaging of drug-eluting and bare-metal stents. Circ Cardiovasc Interv, 2013,6(5):507–517
Nusca A, Viscusi MM, Piccirillo F, et al. In Stent Neoatherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches. Life (Basel), 2022,12(3):393
Park SJ, Kang SJ, Virmani R, et al. In-stent neoatherosclerosis: a final common pathway of late stent failure. J Am Coll Cardiol, 2012,59(23):2051–2057
Borovac JA, D’Amario D, Niccoli G. Neoatherosclerosis and Late Thrombosis After Percutaneous Coronary Intervention: Translational Cardiology and Comparative Medicine from Bench to Bedside. Yale J Biol Med, 2017,90(3):463–470
Nakazawa G, Vorpahl M, Finn AV, et al. One step forward and two steps back with drug-eluting-stents: from preventing restenosis to causing late thrombosis and nouveau atherosclerosis. JACC Cardiovasc Imaging, 2009,2(5):625–628
Handelsman Y, Jellinger PS, Guerin CK, et al. Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Management of Dyslipidemia and Prevention of Cardiovascular Disease Algorithm - 2020 Executive Summary. Endocr Pract, 2020,26(10):1196–1224
Farb A, Kolodgie FD, Hwang JY, et al. Extracellular matrix changes in stented human coronary arteries. Circulation, 2004,110(8):940–947
Araki T, Nakamura M, Sugi K. Characterization of in-stent neointimal tissue components following drug-eluting stent implantation according to the phase of restenosis using a 40-MHz intravascular ultrasound imaging system. J Cardiol, 2014,64(6):423–429
Cui Y, Liu Y, Zhao F, et al. Neoatherosclerosis after Drug-Eluting Stent Implantation: Roles and Mechanisms. Oxid Med Cell Longev, 2016,2016:5924234
Wang H, Wang Q, Hu J, et al. Global research trends in in-stent neoatherosclerosis: A CiteSpace-based visual analysis. Front Cardiovasc Med, 2022,9:1025858
Wang ZW, Chen J, Zeng ZL, et al. The LOX-1 receptor ectopically expressed in the liver alleviates atherosclerosis by clearing Ox-LDL from the circulation. Mol Med, 2022,28(1):26
Wang ZW, Guo XP, Zhang Q, et al. Elimination of Ox-LDL through the liver inhibits advanced atherosclerotic plaque progression. Int J Med Sci, 2021,18(16):3652–3664
Zhang Q, Du GH, Tong L, et al. Overexpression of LOX-1 in hepatocytes protects vascular smooth muscle cells from phenotype transformation and wire injury induced carotid neoatherosclerosis through ALOX15. Biochim Biophys Acta Mol Basis Dis, 2023,1869(8):166805
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
The authors declare that they have no competing interests.
Additional information
This work was supported by grants from the National Natural Science Foundation of China (Nos. 82070376 and 81873491).
Rights and permissions
About this article
Cite this article
Guo, Ys., Yang, N., Wang, Z. et al. Research Progress on the Pathogenesis and Treatment of Neoatherosclerosis. CURR MED SCI 44, 680–685 (2024). https://doi.org/10.1007/s11596-024-2915-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11596-024-2915-x